25
Blood cancer patients plead officials to resume pricing talks for cutting-edge treatment
(www.theglobeandmail.com)
Nearly 1,000 Canadians with multiple myeloma and their caregivers have e-mailed elected officials asking that pricing talks resume for a cutting-edge immunotherapy that Health Canada approved nearly three years ago but which still isn’t available in this country.
The letter writers are pleading with the pan-Canadian Pharmaceutical Alliance, the organization that negotiates confidential discounts on drug prices on behalf of provinces and territories, to cut a deal for Carvykti, a bespoke, one-time-only infusion for the aggressive blood cancer.
From The Globe and Mail via this RSS feed
0
Ex-IDF Legal Chief Who Leaked Sde Teiman Rape Video Arrested After Going Missing
(www.commondreams.org)